- Experimental pill may become 'new standard' for pancreatic cancer 📹 CNN — · 1min
- New cancer treatment trial 📹 CTV News — · 1min
- What makes promising pancreatic cancer drug different from chemotherapy? CBS News —
- Breakthrough treatment for pancreatic cancer 📹 NBC News — · 2min
- Promising new treatment for pancreatic cancer doubles survival rates PBS —
- The Sylvers star Foster Sylvers dead at age 64: Former child star passes in hospice following cancer battle Daily Mail —
- Experimental drug shows promise against deadly pancreatic cancer PBS —
- Why this new pill for a deadly cancer has doctors excited The i Paper —
- Pancreatic cancers: New drug doubles survival rate as France rolls out prevention program Le Monde —
- Revolution Medicines reports Phase 3 win in pancreatic cancer Seeking Alpha —
- Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. ‘I actually started crying’ Fortune —
- New drug nearly doubles survival rates in some pancreatic cancer patients, study says CBS News —
- Experimental pill promises new hope for deadly pancreatic cancer Boston Globe —
- Postman, 61, sues hospital after surgery on pancreas finds benign nodule The Standard —
- New pill for advanced pancreatic cancer patients helps double survival time Daily Record —
- Experimental pill promises new hope for deadly pancreatic cancer ABC News —
- Revolution's pancreatic cancer drug doubles survival, boosts quality of life - Reuters Reuters —
- New drug offers ‘large step forward’ to treat advanced pancreatic cancer al.com —
- Experimental pancreatic cancer pill doubles survival, boosts quality of life The Straits Times —
- Experimental pill promises new hope for deadly pancreatic cancer NPR —
Daraxonrasib
Pharmaceutical compound
Daraxonrasib (RMC-6236) is a RAS inhibitor drug. It is undergoing testing by Revolution Medicines to treat advanced solid tumors with RAS mutations, especially metastatic pancreatic ductal adenocarcinoma (PDAC) containing KRAS G12X mutations. It received a breakthrough therapy designation from the US FDA in 2025.
Also known as...
RMC-6236
Pancreatic Cancer Pill Doubles Survival